New Mexico Cancer Center offering advanced breast cancer fighting technology ...
Still, shares fell by nearly 20% after the company revealed a delay in the coming launch of Revtorpyk. Details in the drug’s ...
Jessie J split from Chanan Colman "some time ago".The 38-year-old singer had been dating the basketball player since 2021 but ...
Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).
Key Points Interested in OnKure Therapeutics, Inc.? Here are five stocks we like better. OnKure Therapeutics is advancing two ...
Investigators examined the effect of postpartum status on the 21-gene Oncotype DX Recurrence Score in women with hormone ...
“She told me to go and get it checked and I laughed. I said, ‘Don’t be silly. Men don’t get breast cancer,’ “ Phil Smith ...
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of ...
Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers ...
The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...
Alison McCullough was in the best shape of her life and preparing for New York Fashion Week when she found a lump under her ...
Atossa Therapeutics, Inc. (NASDAQ: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results